SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

3B Blackbio Dx zooms after its Agro-chemical division receives export order worth Rs 1.59 crore

11 Jan 2024 Evaluate

3B Blackbio Dx is currently trading at Rs. 834.00, up by 20.60 points or 2.53% from its previous closing of Rs. 813.40 on the BSE.

The scrip opened at Rs. 823.95 and has touched a high and low of Rs. 847.90 and Rs. 823.95 respectively. So far 3024 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 924.00 on 04-Jan-2024 and a 52 week low of Rs. 378.90 on 14-Feb-2023.

Last one week high and low of the scrip stood at Rs. 917.80 and Rs. 805.10 respectively. The current market cap of the company is Rs. 630.61 crore.

The promoters holding in the company stood at 38.43%, while Institutions and Non-Institutions held 4.56% and 57.00% respectively.

3B Blackbio Dx’s Agro-chemical division has received an export order for TEMEPHOS 50% EC (KILOTHUS), which is a larvicide. The said order is valued at $1,92,800.00 and in Indian Currency Rs 1.59 crore. TEMEPHOS is mainly used as a larvicide to control mosquitoes, including in domestic water containers and those used for storing drinking-water. With growing global concern for mosquito-borne diseases, this product will have a good future to combat the problem.

3B Blackbio DX (previously known as Kilpest India) is a leading Indian company in the field of PCR based Molecular Diagnostic Kits. 

3B Blackbio Dx Share Price

1309.90 63.60 (5.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 534.85
Poly Medicure 1468.25
Laxmi Denta 195.10
Nureca Ltd. 263.80
Hemant Surgical Inds 297.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×